Introduction
Molting is a complex physiological process that is essential for organismal growth of Pancrustacean species. Due to the presence of a hard exoskeleton, these animals grow discontinuously during their life cycle. In decapod crustaceans, molting is controlled by a neurosecretory center in the eyestalk ganglia, the X-organ/sinus gland (XO/SG) complex, which produces molt-inhibiting hormone (MIH) and other neuropeptides (reviewed in Hopkins, 2012; Webster, 2015) . Increasing titers of ecdysteroids, synthesized by the molting gland, or Y-organ (YO), coordinate synthesis of a new exoskeleton, degradation of the old exoskeleton, limb regenerate growth, and claw muscle atrophy during the premolt stage (reviewed in Hopkins and Das, 2015; Mykles, 2001 Mykles, , 2011 Mykles and Medler, 2015; Skinner, 1985) . The blackback land crab, Gecarcinus lateralis, is a well-established model for studying molting physiology, as molting can be experimentally manipulated. Molting is induced by either eyestalk ablation (ESA) or multiple leg autotomy (MLA), and molting can be suspended in early premolt by autotomy of a limb regenerate (reviewed in Chang and Mykles, 2011; Mykles, 2001; Skinner, 1985) .
There are several signaling pathways that drive transitions in physiological properties of the YO over the molt cycle. MIH inhibits YO ecdysteroidogenesis during intermolt by way of a cyclic nucleotidedependent signaling pathway involving NO synthase (NOS) and NOdependent guanylyl cyclase (GC-I) (reviewed in Chang and Mykles, 2011; Covi et al., 2009 Covi et al., , 2012 Webster, 2015) . A reduction in MIH release from the SG initiates molting processes; the YO transitions from the basal state in intermolt (IM or stage C 4 ) to the activated state in early premolt (EP or stage D 0 ) . Increased ecdysteroidogenesis requires mTOR activity, as rapamycin, an inhibitor of mTOR Complex 1 (mTORC1; Saxton and Sabatini, 2017) , suppresses YO ecdysteroid secretion in vivo and in vitro (Abuhagr et al., 2014b; Abuhagr et al., 2016) . The activated YO remains sensitive to MIH and other factors (reviewed in Chang and Mykles, 2011) . At mid premolt (MP or stage D 1 ), the animal becomes committed to molt; the transition of the YO from the activated to committed state requires a myostatin (Mstn)/activin-like transforming growth factor-beta (TGFβ)-like factor, as ESA increases Gl-Mstn expression in the YO and injection of SB431542, an inhibitor of activin receptor signaling, delays the increase in hemolymph ecdysteroid titers and YO expression of mTOR signaling genes in eyestalk-ablated G. lateralis (Abuhagr et al., 2016) . During late premolt (LP or stage D 2 ), YO ecdysteroid synthesis reaches its highest level and hemolymph titers rise further. At the end of premolt (stage D 3-4 ), the YO transitions to the repressed state, in which ecdysteroidogenesis is greatly reduced and postmolt (PM) ecdysteroid titers are at their lowest (reviewed in Chang and Mykles, 2011; Mykles, 2011) . It is hypothesized that YO repression results from negative feedback by the ecdysteroid peak 2-3 days before ecdysis (reviewed in Chang and Mykles, 2011) .
High throughput sequencing (RNA-Seq) is a powerful tool for identifying and characterizing genes involved in physiological processes. Transcriptomes of de novo-assembled RNA-Seq data have been applied to a variety of decapod crustacean species in studies of immune and stress responses; reproduction, development, and metamorphosis; molting and limb regeneration; neurophysiology; and evolution and ecology (reviewed in Mykles et al., 2016) . Comprehensive annotated transcriptomes have been generated from the YOs of G. lateralis and crayfish, Pontastacus leptodactylus (Tom et al., 2013; Shyamal et al., 2018) . Analysis of these transcriptomes identified oxidoreductases involved in ecdysteroid synthesis and metabolism (Tom et al., 2013; Shyamal et al., 2018) . G. lateralis transcriptomes were produced from three biological replicates of YOs from intermolt animals and animals induced to molt by ESA (Shyamal et al., 2018) . Analysis of these YO transcriptomes identified components of the MIH, mTOR, and activin/TGFβ signaling pathways, some of which were isolated previously by RT-PCR cloning (Abuhagr et al., 2014b; MacLea et al., 2012 ). An unanticipated result was the large diversity of signaling pathway genes represented in both transcriptomes, including MAP kinase, Notch, Wnt, ErbB, Hedgehog, VEGF, and Jak-STAT . These data suggest that the YO can detect and integrate a variety of physiological and environmental signals.
The goal of this study is to identify and characterize genes associated with the basal, activated, committed, and repressed states of the YO. The hypothesis is that each state represents a discrete physiological phenotype with unique gene expression profiles. A YO transcriptome was generated from the assembly of RNA-Seq data from cDNA libraries representing five molt stages: IM (stage C 4 ), EP (stage D 0 ), MP (stage D 1 ), LP (stage D 2 ), and PM (10 days postecdysis; stage B). The three IM libraries that constituted the baseline transcriptome were incorporated into the YO reference transcriptome reported here. The 229,278 contigs in the YO reference transcriptome were annotated and assigned to KEGG orthology pathways, including those of 23 signal transduction pathways. Relative gene expression was quantified between 5 pairwise comparisons of progressive molt stages. Global gene expression, as well as expression of 23 signal transduction pathway genes, was examined. There was a dramatic down-regulation of most genes in PM, indicating that YO was in the repressed state. There were molt stage-specific changes in MIH, mTOR, activin/TGFβ, MAP kinase, Wnt, and Notch signaling pathway genes.
Materials and methods

Animals and experimental treatment
Adult males of Gecarcinus lateralis were collected from the Dominican Republic and shipped to Colorado. Animal care and molt staging are described previously (Covi et al., 2010) . Animals were induced to molt by autotomy of 8 walking legs (multiple leg autotomy or MLA) (Skinner, 1985) . Hemolymph and YOs were collected from animals in one of five molt stages: IM (stage C 4 ), EP (stage D 0 ), MP (stage D 1 ), LP (stage D 2 ), and 10 days PM. Hemolymph (100 μl) was combined with 300 μl methanol and stored at −20°C. Hemolymph ecdysteroid titers were quantified by competitive ELISA (Abuhagr et al., 2014b) . Ecdysteroid titer and limb regeneration index (R-index) were used to pool the YOs for three biological replicates of each molt stage (Yu et al., 2002) . YOs were stored in RNAlater (Ambion®, California) at −20°C.
Library preparation and sequencing
YOs from 2 to 3 individuals from the same stage were pooled for RNA isolation, cDNA synthesis, and sequencing. Total RNA was isolated using RNeasy Mini Kit (Qiagen, Maryland) . mRNA isolation, cDNA synthesis, adapter ligation, and sequencing were conducted at the Oklahoma Medical Research Foundation Genomics facility as described . Library preparation was based on the Illumina TruSeq stranded protocol for the Illumina HiSeq™ 2000 sequencer to generate 15 libraries containing 100 bp paired-end reads (Illumina, California).
Transcriptome assembly, annotation, and differential expression analysis
Paired-end, 100-bp reads were examined for quality using FastQC (Andrews, 2010) . Reads were trimmed with Trimmomatic to remove adapters and low-quality sequences (Bolger et al., 2014) . Trimmed paired and unpaired reads were assembled into contigs using Trinity (Grabherr et al., 2011) . Contigs with 90% nucleotide similarity were clustered using CD-HIT-EST (Fu et al., 2012) . The resulting contig database was the reference transcriptome used for downstream analysis. Trimmed reads from each library were separately aligned to the reference transcriptome using Bowtie2 for expression and to evaluate assembly quality (Langmead and Salzberg, 2012) . SAMtools was used for post-processing of alignment file. Transcript expression levels (counts and FPKMs) were estimated by using eXpress tool (Roberts and Pachter, 2013) . The tool versions and mapping pipeline are specified in Fig. S1 .
The reference transcriptome was filtered to increase the statistical power of limma + voom in identifying differentially expressed contigs between the molt cycle stages. BLASTx searches against four databases (NCBI non-redundant, SwissProt, Uniprot-Uniref90, and UniprotTrEMBL) were used as input for MEtaGenome ANalyzer (MEGAN5) software to sort the hits taxonomically (Huson et al., 2007; . Contigs that encoded viral or prokaryotic sequences or had count values that were disproportionately large (approximately 2 million per library) were removed. Correlations between biological replicates were first evaluated using Kendall tau's correlation coefficient. Libraries with low similarity to respective biological replicates were filtered out. From the remaining database, contigs were selected for the differential expression pipeline, with a cut-off of > 1 count per million reads in two or more libraries using edgeR v.3.16.5 (Robinson et al., 2010) . The count data of the resulting filtered contigs were used for downstream analysis. The RUVSeq package (v.1.8.0) was used for normalization by identifying and removing unwanted variations using the original count data and the surrogate variable analysis (Leek and Storey, 2007; Risso et al., 2014) . The limma + voom package (v.3.30.13) calculated the mean-variance of log counts for each contig and fitted data using empirical Bayes pipelines (Law et al., 2014; Ritchie et al., 2015) . The expression levels of individual genes across five molt cycle stages were analyzed using one-way ANOVA and Tukey post-hoc test on five pairwise comparisons (IM to EP, EP to MP, MP to LP, LP to PM, and PM to IM). Based on the gene-wise p-values, the corresponding q-values were calculated using the fdrtools R package (v.1.2.15) to identify the differentially expressed contigs. The criteria used for identifying differentially-expressed contigs were a q-value of < 0.05 and log 2 -fold changes of < −2 or > 2.
A comprehensive functional annotation of the YO transcriptome from intermolt G. lateralis was published . Here we report for the YO the annotation of the filtered data from a differential expression pipeline over the molt cycle. KEGG (Kyoto Encyclopedia of Genes and Genomes) and KOBAS 2.0 (KEGG Orthology Based Annotation System) databases were used to identify the components of 23 signal transduction pathways. The KEGG Orthology (KO) database was downloaded from KOBAS and sequences from 7 species (Homo sapiens, Drosophila melanogaster, Nasonia vitripennis, Tribolium casteneum, Bombyx mori, Ixodes sapularis, and Harpegnathos saltator) were extracted. KOBAS was used to assign KO to BLASTx hits against speciesspecific sequences using an E-value cut-off < 1e-20 and Rank 1 (Xie et al., 2011) . The signal transduction pathway mappings were conducted via KEGG against the reference KO database.
Computational resources and statistical analyses
The Cowboy server at Oklahoma State University was used for transcriptome assembly, expression quantification, and annotation. Filtering, differential expression, and statistical analyses were completed in RStudio Version 0.99.486 with R version 3.2.2 (64-bit). Sequence extraction and manipulation for enriched pathways used custom perl scripts (v5.22.1). . There were three biological replicates for each molt stage, with each replicate consisting of RNA from two or three pairs of YOs (see Materials and Methods). Hemolymph ecdysteroid titers were low in IM (1.2 ± 0.2 pg/μl, n = 9), increased during premolt (EP = 21.5 ± 11.5 pg/μl, n = 9; MP = 45.4 ± 5.6 pg/μl, n = 9; LP = 130.3 ± 20.1 pg/μl, n = 9), and low in PM (1.0 ± 0.9 pg/μl, n = 7). The R-index ranges from zero immediately after leg autotomy to a maximum of 22-24 at the end of the premolt period (Yu et al., 2002) . The R-indexes from crabs at the EP, MP, and LP stages were 14.1 ± 0.1, 16.8 ± 0.1, and 20.6 ± 0.6, respectively (n = 9 per stage).
Results
3
Sequencing of the 15 YO libraries generated a total of 616,916,101 paired-end reads. The~568 million reads (both paired and unpaired) that remained after trimming to remove adapters and low quality reads were de novo assembled using Trinity (Table 1 ; Fig. S1 ). The assembled transcriptome consisted of 362,494 contigs and, following elimination of redundant sequences via CD-HIT-EST, a total of 229,780 contigs constituted the YO reference transcriptome (Fig. 1) . Individual reads mapped back to the reference transcriptome at an average rate of 94.2%, indicating high fidelity of the reference transcriptome assembly.
Raw counts and normalized transcript expression values as FPKM units were calculated for each contig in the reference transcriptome. Before running a differential expression package, diagnostics were conducted on the count data to remove outliers and normalize the counts across the 15 libraries. The pipeline used for differentially expressed gene (DEG) analyses is shown in Fig. 1 . Using MEGAN, 1592 contigs were identified as viral or prokaryotic sequences and were eliminated from further analysis. The correlation coefficients of count data between the biological replicates indicated that the gene expression profile of the PM1 library was significantly different from the PM2 (Kendall's tau = 0.259; Pearson R 2 = 0.117) and PM3 (Kendall's tau = 0.259; Pearson R 2 = 0.115) libraries (Table S1 ). Consequently, the PM1 library was excluded from further analysis. Three outlier contigs with count values of > 2 million were removed from the dataset (c241624_g1_i1, c241624_g3_i1, and c196747_g1_i2). Removing other contigs with low counts resulted in a dataset with 48,590 contigs, which was designated the filtered transcriptome ( Fig. 1 ; Table 1 ; see Materials and Methods). The libraries were sequenced in three separate Illumina runs, which introduced a variation that necessitated normalization of the count data. The RUVSeq package, specifically the replicate sample normalization method, was used to remove any unknown variation (Risso et al., 2014) . The resulting normalized counts were used in the downstream differential expression analyses via the limma + voom package (Fig. 1) . Normalization improved the statistical power based on the count data of the 14 libraries ( Fig. 2 and Fig. S2 ). Principle component analysis (PCA) before normalization showed discrete grouping of the molt stage replicates into three distinct clusters: IM, premolt (EP, MP, and LP), and PM (Fig. 2) . Normalization resulted in grouping of the EP, MP, and LP replicates into distinct subclusters ( Fig. 2 ).
Global gene expression in the YO over the molt cycle
There were significant changes in global gene expression in the YO over the molt cycle. The five progressive pair-wise comparisons used in the DEG analysis were for the IM to EP, EP to MP, MP to LP, LP to PM, and PM to IM transitions (Fig. 3) . The dataset included all 48,590 contigs in the filtered transcriptome. Parameter cut-offs for the DEG analysis were 0.05 q-value and at least a 4-fold change, in order to focus on those contigs that showed significant changes in the pair-wise comparisons. Volcano plots showed changes in relative expression for the IM/EP, EP/ MP, MP/LP, LP/PM, and PM/IM transitions (Fig. 3A) . A total of 28,179 unique contigs, or 58%, of the filtered transcriptome was identified as differentially expressed between at least one pair-wise comparison, but the number and percentage varied between the five pairwise comparisons. The total number of DE contigs ranged from a low of 372 (1%) contigs for the EP/MP transition to 18,161 (65%) contigs for the LP/PM transition (Fig. 3B ). The number of DE contigs was 16,142 (57%) for the IM/EP transition; 1502 (5%) for the MP/LP transition; and 8281 (29%) for the PM/IM transition (Fig. 3B ). There were significant differences in the number of up-and down-regulated DE contigs between the molt stage comparisons (Fig. 3B ). For the IM/EP comparison, 11,324, or 70%, of the 16,142 contigs were down-regulated (Fig. 3B) . By contrast, a majority of the DE contigs was up-regulated in the next three molt stage comparisons: 283 (76%) for EP/MP; 1272 (85%) for MP/LP; and 12,595 (69%) for LP/ PM (Fig. 3B ). For the PM/IM comparison, 3852 (47%) of the 8281 DE contigs were up-regulated (Fig. 3B) . Of the 28,179 unique DE contigs, only 19 had significant changes in expression levels in all five transitions (data not shown).
Of the 28,179 DE contigs, 13,379 contigs, or 48%, were annotated by Trinotate and BLAST (see Materials and Methods; Fig. 1 ). The number and percentage of the annotated DE contigs differed significantly between the molt stage comparisons: 7668 (48%) for IM/EP; 189 (51%) for EP/MP; 225 (15%) for MP/LP; 8275 (46%) for LP/PM; and 4502 (54%) for PM/IM (Fig. 3B) . Moreover, there were also significant differences in the proportion of up-and down-regulated annotated and non-annotated DE contigs. The percentages of up-regulated non-annotated contigs ranged between 17% for PM/IM and 76% for MP/LP (Fig. 3B ). The percentages of down-regulated non-annotated contigs ranged between 9% for EP/MP and MP/LP to 34% for IM/EP (Fig. 3B) . The data in Fig. 3 are presented as relative expression; it does not represent absolute changes in contig levels. Displaying only relative expression of the DEG data will not reveal biologically significant changes in absolute levels. Table S2 compares the median and mean transcript abundance (FPKM) as indicators for the distribution of the DE contig levels in the datasets of the five molt stage comparisons. The means were greater than the medians in all stages, which indicated that the data were skewed by a relatively small number of contigs that were expressed at high levels. In other words, most of the DE contigs were expressed at lower levels. The medians differed between the molt stages, ranging between 0 FPKM for the PM stage in the LP/PM and PM/IM comparisons and 14.3 FPKM for the LP stage in the MP/LP comparison (Table S2 ). The PM stage had the largest numbers and percentages of DE contigs with an FPKM of zero: 14,067 (77%) for the LP/PM comparison and 5607 (68%) for the PM/IM comparison (Table  S2) . Moreover, 97% and 99% of the PM contigs in the LP/PM and PM/ IM comparisons, respectively, had FPKMs of < 5 (Table S2 ). By contrast, the numbers of the DE contigs with 0 FPKM ranged from 6 to 532 for the molt stages in the IM/EP, EP/MP, and MP/LP comparisons (Table S2 ). The LP stage for the LP/PM comparison had 1875 DE contigs (10%) with 0 FPKM and 13,687 DE contigs (75%) with < 5 FPKM (Table S2 ).
Differential expression of signaling pathway genes
A goal was to identify signaling pathway genes that are associated with molt stage transitions of the YO. KEGG orthologs (KO) analysis was used to annotate all contigs from the filtered transcriptome dataset (48,590 contigs) to map the contigs to signal transduction pathways. Following BLASTx against sequences from seven species, 7656 contigs were assigned KO terms (Fig. 1 ). Of these annotated contigs, 878 (11%) were mapped to 23 KEGG signal transduction pathways (Table 2) . There was a total of 478 (54%) contigs that were differentially expressed (Table 2) . Almost all (96%) of the 279 DE contigs in the transition from IM to EP were down-regulated (Table 3 ). There were relatively few DE contigs in the EP/MP and the MP/LP comparisons. Five of the five DE contigs for EP/MP and one of the four DE contigs for MP to LP were down-regulated (Table 3) . For the LP/PM and PM/IM comparisons, 88 (31%) and 41 (22%) contigs were down-regulated, respectively. A heatmap was generated to show the relative expression profiles of the 478 DE contigs over the molt cycle (Fig. 4 ). There were three general profiles. Many of the contigs showed highest relative expression in IM, decreasing expression during premolt, and lowest relative expression in PM (profile 1). Some contigs showed sustained expression at IM, EP, MP, and LP and low expression at PM (profile 2), while others showed highest relative expression in EP (profile 3) (Fig. 4) .
MIH maintains the YO in the basal state during the IM stage. A reduction in MIH release from the SG initiates YO activation and the animal transitions from IM to EP. The proposed MIH signaling pathway includes adenylyl cyclase (adcy), protein kinase A (pka), nitric oxide synthase (nos), guanylyl cyclase I (gcI), calmodulin (calm), calcineurin (caln), and protein kinase G (pkg) (reviewed in Chang and Mykles, 2011) . All the components of proposed MIH signaling pathway, as well as elongation factor 2 (ef2) and guanylyl cyclase-III (gcIII), were recovered from the transcriptome. Three full-length contigs encoding adcy (adcy1, adcy2, and adcy9) were recovered. The sequences of the ef2, nos, gcI, and gcIII contigs were the same as the Gl-EF2, Gl-NOS, and Gl-GC-III sequences obtained by RT-PCR (Kim et al., 2004; Lee et al., 2007b) . GC-I is an NO-dependent GC and GC-III is a constitutively active GC that may support GC-I function (Lee et al., 2007a) . Seven (adcy1, adcy2, adcy9, nos, pka, caln, and pkg) of the 10 contigs were expressed at their highest levels in IM (Figs. 5A, 6A ). Calm level increased during premolt and decreased at PM. There was no effect of molt stage on gcI and gcIII levels (Figs. 5A, 6A ). All ten contigs were expressed at their lowest levels in PM.
YO activation and sustained ecdysteroid synthesis requires mTOR activity. The 17 mTOR signaling components recovered from the YO transcriptome were akt (protein kinase B), autophagy related 1 (atg1), cap-gly domain containing linker 1 (clip1), frizzled 1/7 (fzd1_7), growth factor receptor bound protein 2 (grb2), insulin-like growth factor 1 receptor (igf1r), late endosomal/lysosomal adaptor, MAPK and mTOR activator 3 (lamtor3), mechanistic target of rapamycin (mtor), phosphatase and tensin homolog (pten), regulatory associated protein of mTOR complex 1 (raptor), rapamycin-insensitive companion of mTOR (rictor), ras homolog enriched in brain (rheb), S6 protein kinase (s6 k), STE20-related kinase adaptor alpha (strada), tuberous sclerosis complex 2 (tsc2_a and tsc2_b), and eukaryotic translation initiation factor 4E binding protein 1 (ef4ebp). The sequences of akt, mtor, rheb, and s6 k were the same as the Gl-Akt, Gl-mTOR, Gl-Rheb, and Gl-S6K sequences obtained by RT-PCR (MacLea et al., 2012; Abuhagr et al., 2014b) . The KEGG pathway with the DE components is shown in Fig. 8A . Six contigs (atg1, ige1r, tsc2_a, grb2, ef4ebp, and lamtor3) were expressed at their highest levels in IM (Figs. 5B, 6B ). Seven contigs (mTOR, raptor, rictor, s6 k, strada, akt, and clip1) were expressed at high levels in both IM and EP (Figs. 5B, 6B ). Rheb and tsc2_b contig levels were significantly increased from IM to EP and remained elevated in MP and LP (Figs. 5B, 6B). Only two contigs (fzd1_7 and pten) were not differentially expressed over the molt cycle (Figs. 5B, 6B ). All 17 contigs were expressed at their lowest levels in PM.
Activin/TGFβ signaling drives the transition of the YO from the activated to committed state at MP. The activin/TGFβ contig sequences retrieved from the YO transcriptome were myostatin-like (mstn), activin receptor 1 (acvr1), R-Smad (smad2_3), Co-Smad (smad 4), I-Smad (smad6), and bone morphogenetic protein (BMP) and activin membrane-bound inhibitor (bambi) (Fig. 8B) . The sequence of mstn was the same as the Gl-Mstn sequence obtained by RT-PCR (Covi et al., 2008) . Acvr1, smad6, and mstn contigs were expressed at higher levels in IM and EP, although the means were not always statistically significant (Figs. 5C, 6C ). Smad2_3 and smad4 contig levels were highest in EP and MP (Figs. 5C, 6C) . bambi was expressed highly in IM and was significantly down-regulated in premolt stages (Figs. 5C, 6C ). Contigs encoding genes from other ΤGFβ signaling pathways were also retrieved: BMP7 (bmp7), BMP receptor 1B (bmpr1b), chordin (chrd), CREB binding protein (crebbp), cullin 1 (cul1), and R-Smad (smad1) (Fig. 8B) . Five contigs (bmpr1b, chrd, crebbp, bmp7, and cul1) were expressed at their highest levels in IM and were significantly down regulated in the premolt stages (Figs. 5C, 6C ). Smad1 was expressed at higher levels in IM and EP (Figs. 5C, 6C) . The levels of all 12 contigs were lowest in PM.
The PM YO is in the repressed state. Although most the DE genes were expressed at low levels in PM, the hierarchical clustering of the signal transduction DE contigs (Fig. 4) identified four genes that were expressed only in PM: diacylglycerol kinase alpha (dgkA), enolase (eno), troponin-C 2 (tnnc2), and htG (hsp90) ( Table S4) . These genes, which are components of the phospholipase D, HIF-1, calcium, and PI3K-Akt signaling pathways, respectively, had comparatively low or no expression in the IM and premolt stages. The expression levels of these genes ranged between 0.04 and 3.16 FPKM in PM (see supporting data). All four genes were differentially expressed in the LP/PM and PM/IM transitions. Heatmaps revealed three profiles of the changes in relative expression levels of the 39 genes in the MIH, mTOR, and TGFβ signaling pathways (Fig. 6) . Profile 1 was exhibited by 19 contigs; levels were highest in IM, decreased in EP, and remained low in MP, LP, and PM. These included adcy1, adcy2, adcy9, caln, nos, pka, and pkg in the MIH pathway (Fig. 6A) ; atg1, grb2, igf1r, lamtor3, s6 k, and tsc2_a in the mTOR pathway (Fig. 6B) ; and bambi, bmp7, bmpr1b, chrd, crebbp, and cul1 in the TGFβ pathway (Fig. 6C) . Profile 2 showed sustained expression in IM and premolt stages and low expression in PM. These included gcI in the MIH pathway (Fig. 6A) ; akt, clip1, mtor, rictor, pten, ef4ebp, and s6 k in the mTOR pathway (Fig. 6B) ; and smad1 and smad6 in the TGFβ pathway (Fig. 6C) . Profile 3 showed higher expression in premolt stages. Contigs in this profile were gcIII and calm in the MIH pathway (Fig. 6A) ; fzd1_7, raptor, rheb, strada, and tsc2_b in the mTOR pathway (Fig. 6B) ; and acvr1, mstn, smad2_3, and smad4 in the TGFβ pathway (Fig. 6C) .
Using the changes in specific genes, heatmap, and percentage of DE contigs as criteria, we identified several other pathways that were associated with molt cycle stage transitions. Of the 23 pathways analyzed, the MAPK (62%), Notch (61%), and Wnt (65%) signaling pathways had the largest percentages of their respective components that were differentially expressed (Table 2 ). The three expression profiles for most of the MAPK, Wnt, and Notch genes were the same as those observed for the MIH, mTOR, and TGFβ signaling genes: highest expression in IM, lower in premolt, and lowest in PM (profile 1); sustained expression in IM and premolt and low in PM (profile 2); and highest expression in EP (profile 3) (Fig. 7) . Twelve of the 19 MAPK signaling contigs (rras2_b, nfkb2, grb2, rapgef2, mek1, nf1_a, nf1_b, ikbka, ikbkb, mnk, and, sos) showed expression profile 1, four contigs (egfr, nf1_c, fgfr2, and, rap1A) showed profile 2, and three contigs (mras, s6kA-P3, and, kras) showed profile 3 (Fig. 7A) . Fifteen of the 28 Notch signaling contigs (adam17, aph1, fng, cir, numbl, groucho, pen2, crebbp, aph1, ctbp, snw1, jagged, adam17, notch, and, adam17) showed expression profile 1; 8 contigs (numbl_a, rbpsuh, dvl, pcaf, numbl_c, dtx, notch_a, and, psen1) showed profile 2; and 3 contigs (ncstn_a, hdac1, and ncstn_b) showed profile 3 (Fig. 7B) . The jagged and nstcn had highest expression in MP (Fig. 7B) .
Ten of the 29 Wnt signaling contigs (csnk1a, csnk1e_a, csnk1e_b, nlk_a, nlk_b, lrp5_6, groucho_a, fzd9_10, ppn, and, rvbl) showed expression profile 1, 11 contigs (gsk2B, dvl, axin1, fzd_7_a, csnk2A_a, csnk2A_b, csnk2B, ctnnB1, groucho_b, tak1, and, txf7L2_b) showed profile 2, and six contigs (fzd1_7_b, fzd1_7_c, fzd4, fzd5, wnt4, and, tcf7L2_a) showed profile 3 (Fig. 7C ). In addition, wnt5 and wnt7 had highest expression levels in LP stage (Fig. 7C) . The dataset was used to identify markers for specific molt stages. As mentioned in the global gene expression analyses, only 30% of the contigs were up-regulated in the transition from IM to EP. Using the data from KEGG analyses of signal transduction pathways, 11 contigs were identified that were significantly up-regulated in EP (Tables 3,  S3 ). These genes were components of the mTOR, AMPK, PI3K-Akt, calcium, Notch, MAPK, Hippo, and Wnt signaling pathways. There were five genes (V-type H + -transporting ATPase subunit G, amyloid beta A4 precursor protein-binding family B member 1-interacting protein, speckle- type POZ protein, phosphatidylinositol 4-kinase A, and eukaryotic translation initiation factor 4E binding protein 1) that were significantly downregulated from EP to MP. The transition from MP to LP led to significant changes in expression of four genes (tyrosine-protein kinase Src, guanine nucleotide-binding protein subunit alpha-14, secretory phospholipase A2, and serine/threonine-protein phosphatase PP1 catalytic subunit) (Table 3) . There were 195 genes that were significantly up-regulated from LP to PM (Table 3) , but only four genes had FPKM values > 1 (Table S4) . Thus, there were a total of 24 genes that were up-or down-regulated at specific molt stages and may collectively be used as markers for distinguishing the YO states over the molt cycle.
Discussion
A transcriptomics approach was used to analyze gene expression in the YO at five discrete stages of the molt cycle. Gene expression profiles and percentage of DE contigs in the KEGG pathway analyses were used as criteria for identifying signaling genes associated with YO activation, commitment, and repression. Global changes in gene expression that included annotated and non-annotated contigs revealed two important findings: (1) YO activation was associated with the down-regulation of a large number of genes (11,324 genes for IM/EP), while YO commitment was associated with the up-regulation of a small number of different genes (283 genes for EP/MP) and (2) expression of most genes was lowest in the PM stage when compared to other stages (Figs. 3, 4) . A lower number of DE contigs were identified in the EP/MP transition (Fig. 3B) . The PCA analysis showed three major groupings consisting of IM, PM, and premolt (EP, MP, and LP) libraries (Fig. 2) . The proximity of the nine premolt libraries in the PCA analysis indicated that the gene expression profiles of the EP, MP, and LP stages were more similar to each other than they were to either the IM or PM libraries, although the EP, MP, and LP libraries formed distinct groupings after normalization (Fig. 2) . This suggests that, in terms of global gene expression, there were three major transitions: IM to EP; LP to PM; and PM to IM. In other words, YO activation (IM/EP), repression (LP/PM), and restoration of the basal state (PM/IM) were associated with the largest changes in gene expression. YO commitment (EP/MP transition) was associated with a relatively small number of DE contigs. As many of these genes were non-annotated (52% of the DE genes in IM/EP; 50% in EP/MP; 85% in MP/LP; 54% in LP/PM, and 46% in PM/IM), their roles in YO control cannot be assessed.
Most of the contigs from the IM and premolt YOs were expressed at very low levels in PM. The average contig level, expressed as FPKM, for the PM stage was skewed towards zero. Even though contigs with low counts were removed before DE analysis of the filtered transcriptome ( Fig. 1 ), 78% and 83% of the 48,590 contigs in the PM2 and PM3 datasets, respectively, had a count value of zero. The statistical tools used for the DE analysis usually demand removal of contig samples with zero count values. However, this would have eliminated 80% of the contigs that had higher count values in the other four molt stages from the analysis. Although the LP/PM transition had the highest number of DE contigs (18,161; Fig. 3B ), the median FPKM was 0 in PM and 0.5 in LP (Table S2 ). In comparison, the next highest number of DE contigs (16,142) was identified in the IM/EP transition. The median FPKM of the 16,142 DE contigs was 3.5 in IM and 0.8 in EP (Table S2) . Although 30% of the DE contigs in the IM/EP transition were up-regulated, only 3% of the 16,142 DE contigs were at 0 FPKM in EP stage (Table S2) . By contrast, 77% of the DE contigs were at 0 FPKM in the PM stage, even though 69% of the DE contigs were up-regulated in the LP/PM transition (Table S2) . Expression of the DE data as relative fold change in levels can be misleading, as it does not take into account the absolute count values (Fig. 3) . Two contigs can show the same-fold change in expression, but can have different FPKM values. As a hypothetical example, contig #1 may increase from 0.01 to 0.1 FPKM and contig #2 may increase from 1 to 10 FPKM. Both have a 10-fold increase in expression, but the difference in FPKM would be 0.09 for contig #1 and 9 for contig #2. FPKM values that are at or near zero would distort the DE analysis, so that statistically significant changes may not be biologically meaningful. Most of the contigs that were up-regulated in PM had low FPKM values in the LP stage. By contrast, most of the down-regulated genes in the PM stage were expressed at high levels in the IM and premolt stages; these include the MIH, mTOR, and TGFβ signaling genes (Fig. 5) . These data suggest that transcriptional rates are lower in the repressed YO, which corresponds to its low ecdysteroidogenic activity in postmolt (see below).
Intermolt is the molt stage that an animal is not actively engaged in the preparation for, or recovery from, ecdysis. It can vary in duration from months to years in adult decapod crustaceans, depending on nutritional and environmental conditions (reviewed in Aiken and Waddy, 1992; Green et al., 2014; Skinner, 1985) . Low hemolymph ecdysteroid titers are maintained in IM animals by sustained inhibition of the YO by the pulsatile release of MIH from the XO/SG complex in the eyestalk ganglia (reviewed in Chang and Mykles, 2011; Skinner, 1985; Webster et al., 2012) . The basal YO is characterized by low ecdysteroid synthesis and high sensitivity to MIH (reviewed in Nakatsuji et al., 2009; Webster et al., 2012) . Binding of MIH to a membrane receptor initiates a signaling cascade mediated by cyclic nucleotide second messengers (reviewed in Covi et al., 2009 ). The current model links a cAMP/Ca 2+ -dependent phase triggered by MIH binding and a NO/cGMP-dependent summation phase, which inhibits ecdysteroidogenesis between MIH pulses (reviewed in Chang and Mykles, 2011; Covi et al., 2012; Webster, 2015) . A Ca 2+ /CaM-dependent NO synthase has a key role in transmitting and amplifying the triggering signal (Kim et al., 2004; Mykles et al., 2010) . NOS is activated by the combined actions of direct binding of Ca 2+ /CaM and dephosphorylation by calcineurin, a Ca 2+ / CaM-dependent protein phosphatase (Lee and Mykles, 2006) ; reviewed in Chang and Mykles, 2011; Covi et al., 2012) . All the components of the MIH signaling pathway are expressed in the YO (Kim et al., 2004; Lee et al., 2007a; Lee et al., 2007b; Abuhagr et al., 2014a; Pitts et al., 2017) (Table 2 , Fig. 5A ). In insects, NO mediates the inhibition of the PG by regenerating tissues (reviewed in Andersen et al., 2013; Hackney and Cherbas, 2014) . In Manduca sexta, NO donor DETA-NONOate inhibits PG ecdysteroid secretion (DeLalio et al., 2015) . Dilp8, an ILP secreted by damaged imaginal discs, activates NOS in Drosophila PG by binding to relaxin receptor homolog (Lgr3), a G protein-coupled receptor, to inhibit ecdysteroid synthesis (Jaszczak et al., 2015; Jaszczak et al., 2016) . Thus, NOS activity inhibits ecdysteroidogenesis in the molting glands of both insects and crustaceans, but is controlled by different factors. The expression of MIH signaling genes is correlated with changes in YO sensitivity to MIH over the molt cycle. The YO becomes less sensitive to MIH in early premolt and is refractory to MIH in mid to late premolt when the animal is committed to molt (Chung and Webster, 2003; Nakatsuji and Sonobe, 2004; Nakatsuji et al., 2006) ; reviewed in Nakatsuji et al., 2009 ). There was a large decrease in the expression of seven of the 10 genes in the MIH signaling pathway from IM to EP; expression of acdy1/2/9, pka, caln, nos, and pkg remained low in premolt stages and then dropped to lowest levels in PM (Figs. 5A, 6A ). By contrast, the expression of calm was higher in premolt (Figs. 5A, 6A ). There was no effect of molt stage on the expression of NO-dependent GC (gc-I) and NO-independent GC (gc-III) (Figs. 5A, 6A ). These data indicate that there is a lag between MIH signaling gene expression and YO sensitivity to MIH; reduced mRNA levels in the activated YO in EP precede the reduced MIH sensitivity of the committed YO in MP and LP. Presumably, a low turnover of MIH signaling proteins contributes to this lag. Conversely, high expression of MIH signaling genes correlates with high YO sensitivity to MIH in IM animals, and even higher expression levels may confer hypersensitivity under certain conditions. Some G. lateralis individuals are refractory to molt induction by MLA and are considered "blocked"; individuals show no signs of molting three months after MLA (Pitts et al., 2017) . The mRNA levels of five of the 10 MIH signaling genes quantified in the YO from these individuals are two to four orders of magnitude higher than those in the YO of control individuals, suggesting that the YO can be inhibited by low MIH levels in the hemolymph and therefore contributes to the blocked condition (Pitts et al., 2017) .
YO activation is initiated by reduced release of MIH from the XO/SG complex, which is mimicked by ESA. Increased ecdysteroid production by the activated YO in EP requires mTORC1-dependent protein synthesis. mTORC1 stimulates translation of mRNA by phosphorylation of eIF4E-binding protein (4E-BP) and p70 S6 kinase (S6K) (reviewed in Saxton and Sabatini, 2017) . MIH inhibits protein synthesis in the YO, but has no effect on RNA synthesis (Soumoff and O'Connor, 1982; Mattson and Spaziani, 1986b) . ESA increases protein synthesis and a transient increase in RNA synthesis in the YO (Simione and Hoffman, 1975; Gersch et al., 1977) . Cycloheximide, an inhibitor of translation, but not actinomycin D, an inhibitor of transcription, inhibits protein synthesis and ecdysteroidogenesis in the YO (Mattson and Spaziani, 1986a; Mattson and Spaziani, 1986b) ; reviewed in Mattson, 1986 ). mTORC1 inhibitor rapamycin inhibits YO ecdysteroid synthesis and secretion (Abuhagr et al., 2014b; Abuhagr et al., 2016) . Taken together, these data suggest that MIH signaling inhibits YO ecdysteroidogenesis by inhibiting mTORC1-dependent translation of mRNA into protein.
Upon activation by reduced MIH, the increase in ecdysteroid synthetic capacity of the YO is due to an mTORC1-dependent increase in the global translation of mRNA to protein.
YO activation is also associated with the up-regulation of many genes in the mTOR signaling pathway. Molt induction of G. lateralis by MLA or ESA increases expression of mTOR signaling genes as measured by qPCR. In MLA animals, mRNA levels of Gl-mTOR and Gl-Akt are significantly increased in premolt, while molt stage has no effect on GlRheb and Gl-S6K mRNA levels (Abuhagr et al., 2014b) . In ESA animals, mRNA levels of Gl-mTOR, Gl-Akt, and Gl-S6K are increased by 3 days post-ESA, while ESA has no effect on Gl-Rheb mRNA level (Abuhagr et al., 2016) . DEG analysis showed that many of the mTOR signaling genes were up-regulated in IM, EP, and MP stages ( Fig. 5B; 6B) . Expression of mTORC1 components mTOR and Raptor was sustained at high levels in IM, EP, and MP. Rheb GTPase, a key regulator of mTORC1 (reviewed in Heard et al., 2014) , was expressed at high levels in EP and MP (Fig. 5B) . As Rheb is not regulated post-translationally, Rheb mRNA level can be used as a proxy for Rheb protein activity. For example, knockdown of Rheb mRNA decreases mTORC1 activity in Drosophila S2 cells (Yang et al., 2006) . Conversely, over-expression of Rheb stimulates mTORC1 activity and ecdysteroid synthesis in the Drosophila prothoracic gland (PG) (Layalle et al., 2008) . Signaling components both upstream and downstream of mTORC1 were also differentially expressed (Fig. 8) . TSC, which inactivates Rheb, is a dimer composed of TSC1/2. Two contigs encoding TSC2 (tsc2_a and tsc2_b) were identified in the YO transcriptome. The expression of tsc2_a was lower during premolt, while the expression of tsc2_b was higher during premolt (Fig. 5B, 6B) . Akt, which inhibits TSC by phosphorylation, was expressed at higher levels in IM, EP, and MP (Fig. 5B, 6B ). The mTORC1 substrates S6K and EF4EBP were expressed at high levels in IM and EP (Fig. 5B, 6B ). Taken together, the DEG analysis indicates that the mTOR signaling pathway was up-regulated in IM and EP. This expression profile is consistent with the role of mTORC1-dependent protein synthesis and gene regulation in YO activation in EP and increased ecdysteroidogenesis in premolt.
The activin/TGFβ signaling pathway is involved in the transition of the YO from the activated state in EP (stage D 0 ) to the committed state in MP (stage D 1 ). Activation of activin/TGFβ signaling requires mTORC1 activity, as commitment is delayed 14 days in eyestalk-ablated G. lateralis injected with rapamycin (Abuhagr et al., 2016) . The TGFβ superfamily is divided into four groups by ligands (BMP, TGFβ, Activin, and Nodal) and their respective membrane receptors ( Fig. 8B ; reviewed in Heldin and Moustakas, 2016; Luo, 2017) . The activin/ TGFβ signaling genes identified in the YO transcriptome are Mstn, Activin receptor I (acvr1), Smad2/3 (R-Smad), Smad4 (Co-Smad), Smad6 (ISmad), and BAMBI ( Fig. 8B ; ; reviewed in Chaikuad and Bullock, 2016) . Mstn is an activin-like member of the TGFβ family that was first characterized as a gene implicated in regulating protein turnover in G. lateralis muscle (Covi et al., 2008; Covi et al., 2010) and has subsequently been cloned from a variety of decapod species (reviewed in Chang and Mykles, 2011; Mykles and Medler, 2015) . However, Gl-Mstn is also highly expressed in the YO and ESA increases GlMstn mRNA levels 5.5-fold by 3 days post-ESA (Abuhagr et al., 2016) . SB431542, an inhibitor of activin signaling, has no effect on YO activation in eyestalk-ablated G. lateralis, but prevents YO commitment and lowers Gl-mTOR, Gl-Akt, and Gl-Rheb mRNA levels in the YO (Abuhagr et al., 2016) . DEG analysis showed higher expression of Mstn in IM, EP, and MP and higher expression of Smad2/3 (R-Smad) and Smad4 (CoSmad) in EP and MP, while acvr1 expression was unchanged (Fig. 5C,  6C ). I-Smad (Smad6) and BAMBI are inhibitors of TGFβ signaling. ISmad competitively associates with activated Type I receptors to block R-Smad activation, while BAMBI acts as a pseudoreceptor to TGFβ ligands ( Fig. 8B ; reviewed in Miyazawa and Miyazono, 2017) . Expression of Smad6 was unchanged in IM and premolt; by contrast, the expression of BAMBI dropped significantly from IM to EP (Fig. 5C, 6C) . Collectively, these data indicate that the activin/TGFβ signaling pathway mediates YO commitment in MP.
DEG analysis identified additional three signaling pathways that regulate the molting glands of insects and crustaceans: MAP kinase, Notch, and Wnt (Table 2 , Fig. 7) . MAP kinase signaling has opposite effects on the molting glands of the two arthropod groups. In the Drosophila PG, PTTH binding to torso, a receptor tyrosine kinase, activates the MAP kinase pathway to stimulate ecdysteroid synthesis (reviewed in Covi et al., 2012; Niwa and Niwa, 2016; Rewitz et al., 2013; Yamanaka et al., 2013) . In the Scylla serrata YO, MAP kinase signaling, as determined by ERK phosphorylation, is active in the PM and IM, when ecdysteroid synthesis is low (Imayavaramban et al., 2007) . Inhibition of ERK phosphorylation with the MEK inhibitor PD98059 increases protein kinase C (PKC) activity, as well as the activities of two proteins involved in the transport and processing of cholesterol in the steroidogenic pathway (steroidogenic acute regulatory protein or StAR and cytochrome P450scc) in PM and IM (Imayavaramban et al., 2007) . These data suggest that MAP kinase, with the involvement of PKC, inhibits YO ecdysteroidogenesis in PM and IM. However, the effects of activation of PKC with phorbol ester (PMA) are not consistent. PMA inhibits YO ecdysteroid synthesis in crayfish species (Orconectes sp.), but stimulates ecdysteroid synthesis in crab, Cancer antennarius (Mattson and Spaziani, 1987; Spaziani et al., 2001 ). The expression profile of MAP kinase signaling is not consistent with ERK phosphorylation observed in S. serrata: MAP kinase genes were up-regulated in IM but down-regulated in PM (Fig. 7A) . The effects of MAP kinase and PKC signaling on ecdysteroid synthesis in the YO are distinct from the MIH signaling pathway (Spaziani et al., 2001) , which suggests other factors beside MIH can regulate YO ecdysteroidogenesis. Those factors have not been identified.
Many of the components of the Notch and Wnt signaling pathways were differentially expressed over the molt cycle (Table 2 , Fig. 7 ). Both Notch and Wnt mediate short-distance cell-cell communication via direct binding to a membrane ligand for Notch signaling or via autocrine or paracrine mechanisms for Wnt signaling (reviewed in Shimobayashi and Hall, 2014) . Receptors for Wnt and Notch, as well as Hedgehog and Hippo, are highly expressed in the Bombyx mori PG (Alexandratos et al., 2016) . In the Drosophila PG, genetic studies show that Wnt controls gene expression by way of Wnt-dependent cis-regulatory sequences (Archbold et al., 2014) , Hippo/Warts signaling stimulates basal ecdysteroid synthesis (Moeller et al., 2017) , and Hedgehog signaling inhibits ecdysteroid synthesis (Rodenfels et al., 2014) . Notch, Wnt, and Hippo signaling pathways activate mTORC1 (reviewed in Shimobayashi and Hall, 2014) . In mammals, there is extensive cross-talk between TGFβ/Smad and Notch and Wnt pathways with interactions that are determined by the cellular and developmental context (reviewed in Luo, 2017) . Therefore, Notch and Wnt may coordinate ecdysteroid synthesis between YO cells by activating mTOR signaling directly and/ or by activin/TGFβ signaling. To our knowledge, there are no studies on the functions of these pathways in the YO. In Litopenaeus vannamei, twelve Wnt genes are differentially expressed with developmental and molt stages, but expression in the YO was not examined (Du et al., 2018) . The high expression of Wnt5 and Wnt7 in the LP YO (Fig. 7C) suggests that these ligands are involved with the peak in hemolymph ecdysteroid titers at the end of LP and repression of the YO in postmolt. Fig. 7 . Heatmap of the expression of genes in the MAP kinase (A), Notch (B), and Wnt (C) signaling pathways. DE contigs identified by limma-voom analyses are marked with an asterisk by the gene name. DE contigs identified by ANOVA are marked with a plus sign.
B. TGFβ signaling pathway
(caption on next page) Investigation of Notch, Wnt, Hedgehog, and Hippo pathways will certainly provide new insights into how the YO integrates various intrinsic and extrinsic signals.
RNA-Seq data was used as a tool for the identification of 24 genes associated with specific molt stages. Using expression profiles and the percentage of DE contigs in the KEGG analysis as criteria, 11 signaling genes were up-regulated in EP, and therefore associated with YO activation (Tables 3, S3 ). These genes are components of the AMPK, PI3K-Akt, MAPK, calcium, Hippo, Wnt, and Notch signaling pathways. A common target of these signaling pathways is mTOR (reviewed in Huang and Fingar, 2014; Laplante and Sabatini, 2012; Shimobayashi and Hall, 2014) . Other genes were identified as characteristic of the other molt stages: five genes in MP, four genes in LP, and four genes in PM (Table 3, S4) . Collectively, the expression of these genes could be used a diagnostic markers for determining the effects of molt manipulation (e.g., ESA, MLA, and limb bud autotomy) and experimental treatments (e.g., rapamycin and SB431542) on the physiological state of the YO.
Conclusions
The MIH, mTOR, and activin/TGFβ signaling pathways regulate the physiological properties of the YO. Fig. 9 summarizes the results from this study and from previous studies (Abuhagr et al., 2014b; Abuhagr et al., 2016; Shyamal et al., 2018) . The pulsatile release of MIH from the XO/SG complex initiates a cyclic nucleotide cascade that inhibits mTORC1 activity, possibly mediated by cGMP-dependent protein kinase (pkg), and maintains the YO in the basal state (reviewed in Chang and Mykles, 2011; Covi et al., 2012; Mykles et al., 2010) . Reduction of MIH release de-represses the YO; mTORC1-dependent protein synthesis drives YO hypertrophy and increased ecdysteroidogenic capacity and the animal enters EP ; reviewed in Chang and Mykles, 2011) . In insects, mTOR, either via prothoracicotropic hormone (PTTH) or insulin signaling, is required for ecdysteroid synthesis in the PG (Danielsen et al., 2016; ; reviewed in Covi et al., 2012; Niwa and Niwa, 2016; Rewitz et al., 2013; Yamanaka et al., 2013) . The activated YO increases the expression of Mstn ( Fig. 5C ; Abuhagr et al., 2016) , activating the activin/TGFβ signaling pathway to drive the transition of the YO to the committed state. The critical role of Mstn in the EP/MP transition may explain the effects of injecting Mstn dsRNA constructs on molting in three shrimp species. Down-regulation of Mstn with RNAi lengthens the intermolt interval in Fenneropenaeus merguiensis (Zhuo et al., 2017) , Penaeus monodon (De Santis et al., 2011) , and L. vannamei (Lee et al., 2015) . Although YO Mstn expression was not examined in these studies, knocking down the expression of Mstn in the YO could have delayed progression from EP to MP, resulting in a lengthened intermolt interval. In insects, activin/TGFβ signaling mediates PG transitions and responsiveness to PTTH during development (Gibbens et al., 2011; ; reviewed in Niwa and Niwa, 2016; Rewitz et al., 2013; Yamanaka et al., 2013) . The data suggest that there is a negative feedback between mTOR and MIH signaling and a positive feedback between activin/TGFβ and mTOR signaling (Fig. 9) . The activation of mTORC1 coincides with the down-regulation of MIH signaling genes in EP (Figs. 5A, 6A ) and up-regulation of the activin/TGFβ signaling genes in EP and MP (Fig. 5C, 6C) . Moreover, blocking activin/TGFβ signaling with SB431542 decreases expression of Gl-mTOR, Gl-Akt, and Gl-Rheb in the YO (Abuhagr et al., 2016) .
The mechanisms underlying the repression of the YO in the LP/PM transition and the restoration of the YO to the basal state in the PM/IM transition require further study. It is hypothesized that the peak in hemolymph ecdysteroid titer at the end of premolt triggers the repressed state (reviewed in Chang and Mykles, 2011) , although the higher expression of Wnt5 and Wnt7 in LP (Fig. 7C) suggests that Wnt signaling may play a role. Among the significant findings reported here are that the YO remains in the repressed state at least through 10 days post-ecdysis (stage B) and that relative gene expression is low in the repressed YO (Table S2; Figs. 4, 5) . During postmolt (stages A, B, and C 1-3 ), synthesis and calcification of the exoskeleton continues as the endocuticle is deposited; synthesis of the exoskeleton is completed with the deposition of the membranous layer (reviewed in Skinner, 1985) . Hemolymph ecdysteroid titers are at their lowest in PM (reviewed in Mykles, 2011) , which indicates low ecdysteroid synthesis by the YO. A repressed YO may assure that precocious molting does not occur while the exoskeleton is still being synthesized. This means that the transition of the YO back to the basal state, which is inhibited by MIH and is capable of activation by reduced MIH, occurs between stage B and stage C 4 (IM). A transcriptomics approach may reveal signaling pathways that restore the YO to the basal state, which is characterized by higher expression of MIH, BMP/TGFβ, MAP kinase, Notch, and Wnt signaling genes. This and recent studies using transcriptomics of the crustacean and insect molting glands have revealed complex interactions between signaling pathways that integrate the actions of nutrients, growth factors, and hormones on ecdysteroidogenesis with tissue regeneration, developmental stage, and environmental cues to coordinate organismal growth and organ size (Alexandratos et al., 2016; Danielsen et al., 2016; Christesen et al., 2017; Nakaoka et al., 2017; Shyamal et al., 2018) .
The reference YO transcriptome (Fig. 1) is available for download Fig. 8 . KEGG pathways for mTOR (A) and TGFβ (B). Boxes with lavender shading are pathway components identified in YO transcriptome that were not differentially expressed. Boxes with yellow shading identify components that were differentially expressed via ANOVA and limma-voom analyses. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
